J&J To Phase Out Quaternium-15 In Baby Shampoo In Response To Demand
This article was originally published in The Rose Sheet
You may also be interested in...
J&J Relaunches Johnson’s Baby Care As Greener, Gentler, With Fewer Ingredients
The overhaul in line with “modern parents’ preferences” could be what’s needed to rouse the sleepy brand and spur Consumer business growth.
Nicorette, Tylenol Ease J&J's Consumer Pain From Slow Oral Care Sales
J&J’s worldwide OTC drug division sales rose 4.4% to $1bn, driven by the Tylenol and Nicorette brands, the firm reports Oct. 17. Those revenues helped offset softness in the firm’s Listerine and other oral care products due to more competition online from start-ups selling straight to consumers.
Nicorette, Tylenol Ease J&J's Consumer Pain From Slow Oral Care Sales
J&J’s worldwide OTC drug division sales rose 4.4% to $1bn, driven by the Tylenol and Nicorette brands, the firm reports Oct. 17. Those revenues helped offset softness in the firm’s Listerine and other oral care products due to more competition online from start-ups selling straight to consumers.